Effects of age and gender in patients receiving doses of opioids for breakthrough pain proportional to background opioid doses
A partir des données de 9 études incluant 462 patients atteints d'un cancer, cette étude analyse, en fonction de l'âge et du sexe du patient, la survenue d'événements indésirables liés à une administration de produits à base de fentanyl, à des doses proportionnelles au schéma opioïde, pour soulager des douleurs aiguës
Aim : To identify the role of age and gender in analgesic and adverse effects after administering fentanyl products for breakthrough pain (BT), given in doses proportional to opioid doses given for background pain. Methods : Data from nine studies, in which patients with BP were given fentanyl products in doses proportional to their basal opioid regimen, were analyzed. Results : A total 462 patients presenting 1905 episodes of BP were included in this analysis. In older patients, the decrease in pain intensity was more pronounced 15 min after administration of a BP medication. No gender differences were found. No significant differences in frequency and intensity of adverse effects for age and gender were found. Conclusion : Fentanyl products given for BP in doses proportional to background opioid regimen were more effective in older patients without adding risks of adverse effects. Gender did not influence analgesia and adverse effects of fentanyl products.